230 related articles for article (PubMed ID: 23339480)
1. Dendrimer and cancer: a patent review (2006-present).
Cai X; Hu J; Xiao J; Cheng Y
Expert Opin Ther Pat; 2013 Apr; 23(4):515-29. PubMed ID: 23339480
[TBL] [Abstract][Full Text] [Related]
2. Surface modified dendrimers: synthesis and characterization for cancer targeted drug delivery.
Sharma A; Gautam SP; Gupta AK
Bioorg Med Chem; 2011 Jun; 19(11):3341-6. PubMed ID: 21570304
[TBL] [Abstract][Full Text] [Related]
3. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.
Cheng Y; Zhao L; Li Y; Xu T
Chem Soc Rev; 2011 May; 40(5):2673-703. PubMed ID: 21286593
[TBL] [Abstract][Full Text] [Related]
4. Current dendrimer applications in cancer diagnosis and therapy.
Majoros IJ; Williams CR; Baker JR
Curr Top Med Chem; 2008; 8(14):1165-79. PubMed ID: 18855703
[TBL] [Abstract][Full Text] [Related]
5. Dendrimer-based nanoparticles for cancer therapy.
Baker JR
Hematology Am Soc Hematol Educ Program; 2009; ():708-19. PubMed ID: 20008257
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of dendrimer prodrugs.
Kojima C
Expert Opin Drug Metab Toxicol; 2015; 11(8):1303-15. PubMed ID: 26028253
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
Dymock BW; See CS
Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
[TBL] [Abstract][Full Text] [Related]
8. PARP inhibitors in cancer therapy: an update.
Papeo G; Casale E; Montagnoli A; Cirla A
Expert Opin Ther Pat; 2013 Apr; 23(4):503-14. PubMed ID: 23379721
[TBL] [Abstract][Full Text] [Related]
9. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
[TBL] [Abstract][Full Text] [Related]
10. Design considerations for PAMAM dendrimer therapeutics.
Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic and diagnostic applications of dendrimers for cancer treatment.
Wolinsky JB; Grinstaff MW
Adv Drug Deliv Rev; 2008 Jun; 60(9):1037-55. PubMed ID: 18448187
[TBL] [Abstract][Full Text] [Related]
12. Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).
Sacco E; Spinelli M; Vanoni M
Expert Opin Ther Pat; 2012 Nov; 22(11):1263-87. PubMed ID: 23009088
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Oncological Submissions of Dendrimer.
Soni N; Tekade M; Kesharwani P; Bhattacharya P; Maheshwari R; Dua K; Hansbro PM; Tekade RK
Curr Pharm Des; 2017 Aug; 23(21):3084-3098. PubMed ID: 28356042
[TBL] [Abstract][Full Text] [Related]
14. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.
Sharma AK; Gothwal A; Kesharwani P; Alsaab H; Iyer AK; Gupta U
Drug Discov Today; 2017 Feb; 22(2):314-326. PubMed ID: 27671487
[TBL] [Abstract][Full Text] [Related]
15. Targeted nanotechnologies for cancer intervention: a patent review (2010-2016).
Pradeep P; Kumar P; Choonara YE; Pillay V
Expert Opin Ther Pat; 2017 Sep; 27(9):1005-1019. PubMed ID: 28621571
[TBL] [Abstract][Full Text] [Related]
16. Host-guest chemistry of dendrimer-drug complexes. 3. Competitive binding of multiple drugs by a single dendrimer for combination therapy.
Zhao L; Cheng Y; Hu J; Wu Q; Xu T
J Phys Chem B; 2009 Oct; 113(43):14172-9. PubMed ID: 19788172
[TBL] [Abstract][Full Text] [Related]
17. Targeting cancer cells with biotin-dendrimer conjugates.
Yang W; Cheng Y; Xu T; Wang X; Wen LP
Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227
[TBL] [Abstract][Full Text] [Related]
18. Host-guest chemistry of dendrimer-drug complexes. 2. Effects of molecular properties of guests and surface functionalities of dendrimers.
Hu J; Cheng Y; Wu Q; Zhao L; Xu T
J Phys Chem B; 2009 Aug; 113(31):10650-9. PubMed ID: 19603764
[TBL] [Abstract][Full Text] [Related]
19. Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations.
Dara A; Sangamwar AT
Expert Opin Ther Pat; 2014 Aug; 24(8):893-912. PubMed ID: 24898985
[TBL] [Abstract][Full Text] [Related]
20. 2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008-2014).
Leoni A; Locatelli A; Morigi R; Rambaldi M
Expert Opin Ther Pat; 2016; 26(2):149-73. PubMed ID: 26561198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
